recombinant human egf (R&D Systems)
97
Structured Review
R&D Systems
recombinant human egf
Recombinant Human Egf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1276 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+egf/Recombinant+Human+EGF+Protein%2C+CF/pmc13091051-268-9-12
Average 97 stars, based on 1276 article reviews
Recombinant Human Egf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1276 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+egf/Recombinant+Human+EGF+Protein%2C+CF/pmc13091051-268-9-12
Average 97 stars, based on 1276 article reviews
recombinant human egf - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Recombinant:Article Title: Transcriptomic and phenotypic convergence of neurodevelopmental disorder risk genes in vitro and in vivo. Article Snippet: .. After 16–18 h (DIV3), medium was switched to SNaP maintenance Medium: DMEM/F12 with Glutamax, Penn/Strep (1:100), MEM-NEAA (1:100; Life Technologies, cat. no. 10370088), B27 minus Vitamin A (1:50; Life Technologies, cat. no. 12587010), N2 Supplement (1:100; Life Technologies, cat. no. 17502048), Article Title: Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma Article Snippet: .. Primary GBM lines were cultured using the NeuroCultTM NS-A Proliferation Kit (StemCell Technologies, 05751) supplemented with penicillin‒streptomycin (100 IU/ml, Gibco), heparin (2 μg/mL, MedChemExpress), Article Title: Functional characterization of human organic anion transporter 4 (hOAT4) as a pH-dependent citrate transporter in renal proximal tubules. Article Snippet: S2–OAT1, OAT3, and OAT4 cells were established as previously described.11–13 S2 cells transfected with pcDNA3.1(+) (Thermo Fisher Scientific, Waltham, MA, USA) lacking human OATs (hOATs) were used as controls (S2–mock cells). .. Cells were cultured in DMEM/Ham's F-12 medium (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) supplemented with 1 × ITS-G (Insulin–Transferrin–Selenium; Thermo Fisher Scientific), 10 ng/mL Article Title: Lung endothelial niche signaling governs self-renewal and fate transitions of human alveolar stem cells Article Snippet: The complete medium consisted of Advanced DMEM/F12 (Gibco, 12634010) supplemented with Insulin-Transferrin-Selenium (1×; Gibco, 41400045), HEPES (15 mM; Gibco, 15630080), GlutaMAXTM Supplement (1×; Gibco, 35050061), B-27 Supplement minus vitamin A (1×; Gibco, 12587010), N-2 Supplement (1×; Gibco, 17502048), and Antibiotic-Antimycotic (1×; Gibco, 15240062). .. The following additives were included: SB431542 (10 μM; Abcam, ab120163), CHIR99021 (3 μM; Tocris, 4423), BIRB796 (1 μM; Tocris, 5989), Article Title: Host kinase regulation of Plasmodium vivax dormant and replicating liver stages Article Snippet: .. Three days post-plating cells were treated with tucatinib (10nM – 10μM) or a DMSO control for 2 hours before stimulation with 10ng/mL Article Title: Universal donor cells and related methods Article Snippet: .. : hESC aggregates; XF HA: DMEM/F12 containing GlutaMAX, supplemented with 10% v/v of Xeno-free KnockOut Serum Replacement, 1% v/v non-essential amino acids, 1% v/v penicillin/streptomycin (all from Life Technologies), 10 ng/mL heregulin-1β (Peprotech) and 10 ng/mL activin A (R&D Systems); SP: StemPro ® hESC SFM (Life Technologies); r0.2FBS: RPMI 1640 (Mediatech); 0.2% FBS (HyClone), 1x GlutaMAX-1 (Life Technologies), 1% v/v penicillin/streptomycin; ITS: Insulin-Transferrin-Selenium (Life Technologies) diluted 1:5000 or 1:1000; A100: 100 ng/mL recombinant human Activin A (R&D Systems); W50: 50 ng/mL recombinant mouse Wnt3A (R&D Systems); K25: 25 ng/mL recombinant human KGF (R&D Systems); IV: 2.5 μM TGF-β RI Kinase inhibitor IV (EMD Bioscience); db: DMEM HI Glucose (HyClone) supplemented with 0.5x B-27 Supplement (Life Technologies), 1x GlutaMAX, and 1% v/v penicillin/streptomycin; CTT3: 0.25 μM KAAD-Cyclopamine (Toronto Research Chemicals) and 3 nM TTNPB (Sigma-Aldrich); N50: 50 ng/mL recombinant human Noggin (R&D Systems); K50: 50 ng/mL recombinant human KGF (R&D Systems); E50: 50 ng/mL Article Title: Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma. Article Snippet: .. Primary GBM lines were cultured using the NeuroCultTM NS-A Proliferation Kit (StemCell Technologies, 05751) supplemented with penicillin‒streptomycin (100 IU/ml, Gibco), heparin (2 μg/mL, MedChemExpress), Cell Culture:Article Title: Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma Article Snippet: .. Primary GBM lines were cultured using the NeuroCultTM NS-A Proliferation Kit (StemCell Technologies, 05751) supplemented with penicillin‒streptomycin (100 IU/ml, Gibco), heparin (2 μg/mL, MedChemExpress), Article Title: Functional characterization of human organic anion transporter 4 (hOAT4) as a pH-dependent citrate transporter in renal proximal tubules. Article Snippet: S2–OAT1, OAT3, and OAT4 cells were established as previously described.11–13 S2 cells transfected with pcDNA3.1(+) (Thermo Fisher Scientific, Waltham, MA, USA) lacking human OATs (hOATs) were used as controls (S2–mock cells). .. Cells were cultured in DMEM/Ham's F-12 medium (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) supplemented with 1 × ITS-G (Insulin–Transferrin–Selenium; Thermo Fisher Scientific), 10 ng/mL Article Title: AAV immuno-gene therapy platform delivering vectorized cytokines defines a new modality for high-grade glioma treatment Article Snippet: For potency described in A, HEK293T cells were transduced with SRN-101 or AAV9-hFINβ at MOI 5E4, 2E5, 4E5, and 8E5 vg/cell, and cell supernatants were evaluated by ELISA for hIFNβ (PBL Cat#:41410) 48 h after treatment. .. Thereafter, rosette aggregates were further cultured in 10 ng/mL Article Title: Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma. Article Snippet: .. Primary GBM lines were cultured using the NeuroCultTM NS-A Proliferation Kit (StemCell Technologies, 05751) supplemented with penicillin‒streptomycin (100 IU/ml, Gibco), heparin (2 μg/mL, MedChemExpress), Control:Article Title: Host kinase regulation of Plasmodium vivax dormant and replicating liver stages Article Snippet: .. Three days post-plating cells were treated with tucatinib (10nM – 10μM) or a DMSO control for 2 hours before stimulation with 10ng/mL Knock-Out:Article Title: Universal donor cells and related methods Article Snippet: .. : hESC aggregates; XF HA: DMEM/F12 containing GlutaMAX, supplemented with 10% v/v of Xeno-free KnockOut Serum Replacement, 1% v/v non-essential amino acids, 1% v/v penicillin/streptomycin (all from Life Technologies), 10 ng/mL heregulin-1β (Peprotech) and 10 ng/mL activin A (R&D Systems); SP: StemPro ® hESC SFM (Life Technologies); r0.2FBS: RPMI 1640 (Mediatech); 0.2% FBS (HyClone), 1x GlutaMAX-1 (Life Technologies), 1% v/v penicillin/streptomycin; ITS: Insulin-Transferrin-Selenium (Life Technologies) diluted 1:5000 or 1:1000; A100: 100 ng/mL recombinant human Activin A (R&D Systems); W50: 50 ng/mL recombinant mouse Wnt3A (R&D Systems); K25: 25 ng/mL recombinant human KGF (R&D Systems); IV: 2.5 μM TGF-β RI Kinase inhibitor IV (EMD Bioscience); db: DMEM HI Glucose (HyClone) supplemented with 0.5x B-27 Supplement (Life Technologies), 1x GlutaMAX, and 1% v/v penicillin/streptomycin; CTT3: 0.25 μM KAAD-Cyclopamine (Toronto Research Chemicals) and 3 nM TTNPB (Sigma-Aldrich); N50: 50 ng/mL recombinant human Noggin (R&D Systems); K50: 50 ng/mL recombinant human KGF (R&D Systems); E50: 50 ng/mL |